相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines
Isabel Belinchon Romero et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis
Paolo Gisondi et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Risk of hospitalization and death due to infection in people with psoriasis: a population-based cohort study using the Clinical Practice Research Datalink
Z. Z. N. Yiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
The global, regional, and national burden of psoriasis in 195 countries and territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017
Sino Mehrmal et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Role of regulatory T cells in psoriasis pathogenesis and treatment
L. Nussbaum et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Prevalence of psoriasis among adults in the US 2009-2010 and 2013-2014 National Health and Nutrition Examination Surveys
Jeffrey Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2021)
Dose Tapering of Biologics in Patients with Psoriasis: A Scoping Review
C. A. J. Michielsens et al.
DRUGS (2021)
Tissue-Resident Memory CD8+T Cells From Skin Differentiate Psoriatic Arthritis From Psoriasis
Emmerik F. Leijten et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Brazilian Consensus on Psoriasis 2020 and Treatment Algorithm of the Brazilian Society of Dermatology
Ricardo Romiti et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2021)
IL-23 blockade with guselkumab potentially modifies psoriasis pathogenesis: rationale and study protocol of a phase 3b, randomised, double-blind, multicentre study in participants with moderate-to-severe plaque-type psoriasis (GUIDE)
Kilian Eyerich et al.
BMJ OPEN (2021)
Modifiable risk factors and the development of psoriatic arthritis in people with psoriasis
A. Green et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Management of psoriasis as a systemic disease: what is the evidence?
N. J. Korman
BRITISH JOURNAL OF DERMATOLOGY (2020)
Long-term follow-up of patients in the TIght COntrol of inflammation in early Psoriatic Arthritis (TICOPA) trial
Laura C. Coates et al.
RHEUMATOLOGY (2020)
Tissue-resident memory T cells and their biological characteristics in the recurrence of inflammatory skin disorders
Ling Chen et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Emerging molecular biomarkers for predicting therapy response in psoriatic arthritis: A review of literature
Juliette Pouw et al.
CLINICAL IMMUNOLOGY (2020)
A Belgian consensus on the definition of a treat-to-target outcome set in psoriasis management
L. Grine et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
Josef S. Smolen et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Japanese guidance for use of biologics for psoriasis (the 2019 version)
Hidehisa Saeki et al.
JOURNAL OF DERMATOLOGY (2020)
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update
C. H. Smith et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis A Randomized Clinical Trial
Selma Atalay et al.
JAMA DERMATOLOGY (2020)
National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study
Rosa Parisi et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
Laure Gossec et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Modifiable Lifestyle and Environmental Factors Associated with Onset of Psoriatic Arthritis in Patients with Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies
Wenhui Xie et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Association Between Early Severe Cardiovascular Events and the Initiation of Treatment With the Anti-Interleukin 12/23p40 Antibody Ustekinumab
Florence Poizeau et al.
JAMA DERMATOLOGY (2020)
Early Intervention in Ulcerative Colitis: Ready for Prime Time?
Virginia Solitano et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Psoriasis and Treatment: Past, Present and Future Aspects
Claire Reid et al.
ACTA DERMATO-VENEREOLOGICA (2020)
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis
Emilie Sbidian et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2020)
French guidelines on the use of systemic treatments for moderate-to-severe psoriasis in adults
F. Amatore et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)
Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition
Jose U. Scher et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities
Craig A. Elmets et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Resolution of plaque-type psoriasis: what is left behind (and reinitiates the disease)
Theresa Benezeder et al.
SEMINARS IN IMMUNOPATHOLOGY (2019)
Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis
Jasvinder A. Singh et al.
ARTHRITIS CARE & RESEARCH (2019)
Duration of Psoriatic Skin Disease as Risk Factor for Subsequent Onset of Psoriatic Arthritis
Alexander Egeberg et al.
ACTA DERMATO-VENEREOLOGICA (2018)
Consensus on the management of patients with psoriatic arthritis in a dermatology setting
P. Gisondi et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study
L. Iversen et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2018)
Effect of Age of Onset of Psoriasis on Clinical Outcomes with Systemic Treatment in the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Sanminder Singh et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2018)
Clinical and Genetic Risk Factors Associated with Psoriatic Arthritis among Patients with Psoriasis
Di Yan et al.
DERMATOLOGY AND THERAPY (2018)
Early intervention in Crohn's disease: towards disease modification trials
Silvio Danese et al.
GUT (2017)
TNF-α Antagonist and Vascular Inflammation in Patients with Psoriasis Vulgaris: A Randomized Placebo-Controlled Study
Robert Bissonnette et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
The Risk of Developing Diabetes Mellitus in Patients with Psoriatic Arthritis: A Cohort Study
Lihi Eder et al.
JOURNAL OF RHEUMATOLOGY (2017)
Poor early response to methotrexate portends inadequate long-term outcomes in patients with moderate-to-severe psoriasis: Evidence from 2 phase 3 clinical trials
Kenneth B. Gordon et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
From the Medical Board of the National Psoriasis Foundation: Treatment targets for plaque psoriasis
April W. Armstrong et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Risk of Myocardial Infarction in Patients with Psoriasis and Psoriatic Arthritis: A Nationwide Cohort Study
Alexander Egeberg et al.
ACTA DERMATO-VENEREOLOGICA (2017)
Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis
Martin Bergman et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Incidence and predictors for cardiovascular events in patients with psoriatic arthritis
Lihi Eder et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Do Biologics Protect Patients With Psoriasis From Myocardial Infarction? A Retrospective Cohort
Wayne P. Gulliver et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2016)
Genetic prediction of the effectiveness of biologics for psoriasis treatment
Rika Nishikawa et al.
JOURNAL OF DERMATOLOGY (2016)
Consensus document on the evaluation and treatment of moderate-to-severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology
E. Dauden et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
T Helper Cell Subsets in Clinical Manifestations of Psoriasis
Marco Diani et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Psoriasis - The Life Course Approach
M. Dennis Linder et al.
ACTA DERMATO-VENEREOLOGICA (2016)
Think beyond the Skin: 2014 Canadian Expert Opinion Paper on Treating to Target in Plaque Psoriasis
Wayne Gulliver et al.
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY (2015)
Psoriasis and the Risk of Major Cardiovascular Events: Cohort Study Using the Clinical Practice Research Datalink
Rosa Parisi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Prevalence of Psoriatic Arthritis in a Large Cohort of Brazilian Patients with Psoriasis
Roberto Ranza et al.
JOURNAL OF RHEUMATOLOGY (2015)
Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Laura C. Coates et al.
LANCET (2015)
Clinical Risk Factors for the Development of Psoriatic Arthritis Among Patients with Psoriasis: A Review of Available Evidence
Alexis Ogdie et al.
CURRENT RHEUMATOLOGY REPORTS (2015)
Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study
Alexis Ogdie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Diagnostic delay of more than 6 months contributes to poor radiographic and functional outcome in psoriatic arthritis
Muhammad Haroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper
G. Girolomoni et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2015)
PASI90 response: the new standard in therapeutic efficacy for psoriasis
L. Puig
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Concept of Remission in Chronic Plaque Psoriasis
Paolo Gisondi et al.
JOURNAL OF RHEUMATOLOGY (2015)
Risk of mortality in patients with psoriatic arthritis, rheumatoid arthritis and psoriasis: a longitudinal cohort study
Alexis Ogdie et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Early psoriatic arthritis: short symptom duration, male gender and preserved physical functioning at presentation predict favourable outcome at 5-year follow-up. Results from the Swedish Early Psoriatic Arthritis Register (SwePsA)
Elke Theander et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey
Mark G. Lebwohl et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Psoriasis Is Not Associated with Atherosclerosis and Incident Cardiovascular Events: The Rotterdam Study
Emmilia A. Dowlatshahi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis of Observational Studies
Ehrin J. Armstrong et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States Findings From the National Psoriasis Foundation Surveys, 2003-2011
April W. Armstrong et al.
JAMA DERMATOLOGY (2013)
Real-Life Effectiveness of Infliximab in the Treatment of Ankylosing Spondylitis over 3 Years: The Canadian Experience
Proton Rahman et al.
JOURNAL OF RHEUMATOLOGY (2012)
Early Psoriatic Arthritis
Dafna D. Gladman
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2012)
Definition of treatment goals for moderate to severe psoriasis: a European consensus
U. Mrowietz et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2011)
Skin-Resident T Cells: The Ups and Downs of On Site Immunity
Rachael A. Clark
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Psoriasis: is the impairment to a patient's life cumulative?
A. B. Kimball et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2010)
The Risk of Stroke in Patients with Psoriasis
Joel M. Gelfand et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Mechanisms of Disease: Psoriasis.
Frank O. Nestle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Regulatory T cells and immune tolerance
Shimon Sakaguchi et al.
CELL (2008)
Risk of myocardial infarction in patients with psoriasis
Joel M. Gelfand et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Medical progress - Psoriasis
MP Schon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
分享论文
